In our study, the MAP7-associated microRNA profile revealed that in MAP7high CN-AML patients, some oncogenic microRNAs such as miR-196b and miR-99a were up-regulated, whereas anti-tumor microRNAs such as miR-193a and miR-27a were down-regulated. This evidence concerns the gene MAP7 and neoplasm.